Territory Infringement definition

Territory Infringement has the meaning set forth in Section 9.4(a).
Territory Infringement has the meaning set forth in Section 9.4(a). “Third Party” means any entity other than Licensor or Licensee or an Affiliate of either of them or any contract manufacturer. “Third Party Claim” has the meaning set forth in Section 9.5(b). “Third Party Offer” has the meaning set forth in Section 2.4(b). “Third Party Transaction” has the meaning set forth in Section 2.4(a). 14 THE COMPANY HAS REQUESTED AN ORDER FROM THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED, GRANTING CONFIDENTIAL TREATMENT TO SELECTED PORTIONS. ACCORDINGLY, THE CONFIDENTIAL PORTIONS HAVE BEEN OMITTED FROM THIS EXHIBIT, AND HAVE BEEN FILED SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS ARE INDICATED IN THIS EXHIBIT WITH “*****”. “TNF-α” means human tumor necrosis factor-alpha. “TNF-α Development Candidate” means each TNF-α-targeting SNA, including but not limited to, AST-005, designed to modulate, including decreasing or increasing, expression or activity of TNF-α at the gene or mRNA level by the use of Licensor’s SNA Platform Technology, including, but not limited to, antisense, RNA interference (RNAi) or triplex formation. For clarity, the modulation must be designed to directly target the human TNF-α gene or mRNA, and not indirectly through another target. “TNF-α Product” means each Product Derived from a TNF-α Development Candidate for use in the Field and for all Indications. “TNF-α Target” means TNF-α, the expression or activity of which is to be modulated, including decreasing or increasing, at the gene or mRNA level by use of Licensor’s SNA Platform Technology, including, but not limited to, antisense, RNA interference (RNAi) or triplex formation, for use in the Field. For clarity, the modulation must be designed to directly target the human TNF-α gene or mRNA, and not indirectly through another target. “Trigger Date” means the earlier of (i) Licensee’s exercise of the AST-005 Option or (ii) the date that Licensee selects the first (1st) Collaboration Target. “U.S.” means the United States of America, including all possessions and territories thereof. ARTICLE 2

Examples of Territory Infringement in a sentence

  • For any Territory Infringement, each Party will share with the other Party all Information available to it regarding such actual or alleged infringement.

  • For any Licensed Territory Infringement, each Party shall share with the other Party all Information available to it regarding such actual or alleged infringement.

  • During this time, the Employer will not be required to continue to provide healthcare coverage, but the employee will be allowed to continue insurance coverage at the group rate.

  • Licensee will not settle any claim, suit or action that it brought in respect of Territory Infringement that (i) includes any statement that may be used as an admission of invalidity or unenforceability of any Licensor Patents, or (ii) imposes any material obligations on Licensor or admits fault on behalf of Licensor, in each case without Licensor’s prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed.

  • If Licensee fails to commence a suit to enforce the applicable Licensor Patents against such Territory Infringement or to settle or otherwise secure the abatement of such Territory Infringement within one hundred eighty (180) days after becoming aware of such Territory Infringement, then Licensor may commence a suit or take action to enforce such Licensor Patents against such Territory Infringement at its own cost and expense.

  • Allos shall have a period of ninety (90) days after its receipt or delivery of notice under Section 8.5(a) to elect to so enforce the Joint Patents or Mundipharma Patents against such Allos Territory Infringement (or to settle or otherwise secure the abatement of such Allos Territory Infringement).

  • Each party must immediately give to the other party full details of any actual or suspected infringement or any action for revocation of any of the Licensed IP by a third party in the Territory (Infringement) of which it becomes aware.

  • If Licensee fails to commence a suit to enforce the applicable Joint Patents or Licensor Patents against such Territory Infringement or to settle or otherwise secure the abatement of such Territory Infringement within such period, then Licensor may commence a suit or take action to enforce such Joint Patents or Licensor Patents against such Territory Infringement at its own cost and expense.

  • If Mundipharma fails to commence a suit to enforce the applicable Joint Patents, Allos Patents or Mundipharma Patents against such Licensed Territory Infringement or to settle or otherwise secure the abatement of such Licensed Territory Infringement within such period, then Allos shall have the right, but not the obligation, to commence a suit or take action to enforce such Joint Patents, Allos Patents or Mundipharma Patents against such Licensed Territory Infringement at its own cost and expense.

  • As between the Parties, Licensee may bring an appropriate suit or other action against any person or entity engaged in any such Territory Infringement which infringes any Licensee Patent or any Licensor Patent that includes claims directed to any Product, at Licensee’s cost and expense.

Related to Territory Infringement

  • Product Infringement has the meaning set forth in Section 9.4(a).

  • Third Party Infringement has the meaning set forth in Section 5.1.

  • Competitive Infringement has the meaning set forth in Section 7.5.1.

  • Infringement Action has the meaning set forth in Section 9.6(b).

  • Infringement has the meaning set forth in Section 6.3(a).

  • Third Party Infringement Claim has the meaning set forth in Section 23.5.1.

  • Joint Patent Rights means Patent Rights that contain one or more claims that cover Joint Technology.

  • Infringement Claim has the meaning set forth in Section 8.2(a).

  • Licensed Patent Rights means: (a) Patent applications (including provisional patent applications and PCT patent applications) or patents listed in Appendix A, all divisions and continuations of these applications, all patents issuing from these applications, divisions, and continuations, and any reissues, reexaminations, and extensions of these patents; (b) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): (i) continuations-in-part of 2.9(a); (ii) all divisions and continuations of these continuations-in-part; (iii) all patents issuing from these continuations-in-part, divisions, and continuations; (iv) priority patent application(s) of 2.9(a); and (v) any reissues, reexaminations, and extensions of these patents; (c) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): all counterpart foreign and U.S. patent applications and patents to 2.9(a) and 2.9(b), including those listed in Appendix A; and (d) Licensed Patent Rights shall not include 2.9(b) or 2.9(c) to the extent that they contain one or more claims directed to new matter which is not the subject matter disclosed in 2.9(a).

  • Licensed Patent means Stanford's rights in U.S. Patent Application, Serial Number , filed , any foreign patent application corresponding thereto, and any divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP) patent application or patent.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Joint Patent means a patent that issues from a Joint Patent Application.

  • Licensed Territory means worldwide.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • Joint Patents means all Patents claiming any Joint Invention.

  • Patent Rights means all patents and patent applications, including all divisionals, continuations, substitutions, continuations-in-part, re-examinations, reissues, additions, renewals, extensions, registrations, and supplemental protection certificates and the like of any of the foregoing.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Product Patents means any and all United States patents and patent applications, all divisionals, continuations, continuations-in-part, re-issues, extensions or foreign counterparts thereof, now or hereafter owned or controlled ("controlled" being used in the sense of having the right to grant licenses thereunder) by PERIMMUNE, covering the manufacture, use, sale, offer for sale and/or importation of the Product, including but not limited to, the U.S. Patent No. 5,407,912 attached hereto as Exhibit B.

  • Third Party IPR means any Intellectual Property Rights not belonging to either party to this Agreement but used by the Supplier in the creation of the Deliverables and/or in the course of or in connection with the Project.

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or restoration by existing or future extension or restoration mechanisms (including, without limitation, supplementary protection certificates or the equivalent thereof), or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Territory means worldwide.

  • Licensee Patents means any Patents within the Control of Licensee as of the Effective Date and at any time during the Term relating to the Product.

  • Assigned Patent Rights means all of the following, whether now owned or hereafter acquired or arising:

  • Licensed Field means [***].

  • infringement notice has the meaning set forth in Section 7.4.1;